PhaseBio Pharmaceuticals, Inc. (PHAS)

Short-Term Debt

$4.50M

Quarterly · Period ending: · USD

PHAS logo

PHAS Short-Term Debt

Latest reported$5.41M
PHAS FY Short-Term Debt ($0.00 → $5.41M)
High-resolution chart · PNG

PHAS short-term debt history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Short-Term Debt — Annual fiscal periods (USD)
Period endingShort-Term Debt (USD)
5,413,000
5,355,000
2,378,000
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.